2.10.2 Fibrinolytic drugs

Homepage

Search the NeLM

Medicines A-Z

Find key information about medicines by name (prototype)

Browse by Categories:

Browse by NeLM area:

BNF Category

115 library items in 2.10.2 Fibrinolytic drugs

Filter results by:

Date Published

NeLM Area

News
Other Library Updates
Health In Focus
Evidence
Medicines A-Z
Communities
Formularies

Results filtered by:

Category

2: Cardiovascular system (remove) , 2.10 Stable angina, acute coronary syndromes, and (remove) , 2.10.2 Fibrinolytic drugs (remove)

Sort by: Display summary:

Results 1 - 10 of 115

Result page:
Previous
|
1
2
3
4
5
6
7
8
9
10
11
|
Next

1.

How is stroke thrombolysis portrayed in UK national and London local newspapers? A review and critical discourse analysis

Source: Age and Ageing,
Date published: 25/04/2012

Category:

2.10.2 Fibrinolytic drugs | Patient

NeLM Area:

Evidence > Medicines Management > References

Abstract link
2.

License extension: Therapeutic window for alteplase administration in stroke increased to 4.5 hours

Source: MarketWatch,
Date published: 16/04/2012

Category:

2.10.2 Fibrinolytic drugs | Cerebral Ischaemia | Licence extension

NeLM Area:

News

Link

ECAS III study results (NeLM report)
3.

Tenecteplase versus alteplase for acute ischaemic stroke: Phase IIB study

Source: N Engl J Med,
Date published: 22/03/2012

Category:

2.10.2 Fibrinolytic drugs | Stroke

NeLM Area:

News

Abstract
4.

Audit of stroke thrombolysis in Wellington, New Zealand: disparity between in-hours and out-of-hours treatment time

Source: New Zealand Medical Journal,
Date published: 10/02/2012

Category:

2.10.2 Fibrinolytic drugs

NeLM Area:

Evidence > Medicines Management > References

Abstract link
5.

AWMSG issues Final Appraisal Recommendation on the use of alteplase (Actilyse® Cathflo® 2 mg) for unblocking occluded central venous access devices

Source: All Wales Medicines Strategy Group (AWMSG),
Date published: 12/01/2012

Category:

2.10.2 Fibrinolytic drugs | All Wales Medicines Strategy Group (AWMSG) | Drugs in renal failure

NeLM Area:

Evidence > Drug Specific Reviews

Recommendation
6.

Long-term outcome after additional catheter-directed thrombolysis vs. standard treatment for acute iliofemoral deep vein thrombosis (CaVenT study)

Source: Lancet,
Date published: 15/12/2011

Category:

2.10.2 Fibrinolytic drugs | Venous Thromboembolism

NeLM Area:

News

Abstract

Comment- full text access for subscribers only
7.

Intracranial haemorrhage, outcome, and mortality after intraarterial therapy for acute ischaemic stroke in anticoagulated patients

Source: Stroke,
Date published: 02/12/2011

Category:

2.8.2 Oral anticoagulants | 2.10.2 Fibrinolytic drugs | Adverse Drug Reactions | Haematology | Stroke

NeLM Area:

News

Abstract
8.

Analysis suggests stroke history or diabetes should not rule out thrombolysis for acute ischaemic stroke

Source: Neurology,
Date published: 23/11/2011

Category:

2.10.2 Fibrinolytic drugs | Cerebral Ischaemia

NeLM Area:

News

Link (abstract)
9.

Safety and efficacy of a pharmaco-invasive reperfusion strategy in rural STEMI patients

Source: Eur Heart J,
Date published: 31/10/2011

Category:

2.9 Antiplatelet drugs | 2.10.2 Fibrinolytic drugs | Myocardial Infarction

NeLM Area:

News

Link (abstract)
10.

Pharmacy department commitment to a multidisciplinary stroke response team

Source: Pharmacotherapy,
Date published: 28/09/2011

Category:

2.10.2 Fibrinolytic drugs | Cerebral Ischaemia | Hospital pharmacy

NeLM Area:

Evidence > Medicines Management > References

Meeting abstracts link (PDF)

Results 1 - 10 of 115

Result page:
Previous
|
1
2
3
4
5
6
7
8
9
10
11
|
Next